1. Home
  2. Companies
  3. Iovance Biotherapeutics
  4. Financial Ratios
  5. DSO Ratio
Iovance Biotherapeutics logo
Iovance Biotherapeutics IOVA
$ 3.82 0.0%

Annual report 2025
added 02-24-2026

report update icon

Iovance Biotherapeutics DSO Ratio 2011-2026 | IOVA

Annual DSO Ratio Iovance Biotherapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
105 77.3 23.2 - - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
105 23.2 68.5

Quarterly DSO Ratio Iovance Biotherapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
85.7 99.6 130 - 68.1 46.7 24.6 - - 6.33 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
130 6.33 65.8

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
 		48.3 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		222 - - $ 86.2 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		16.2 K $ 3.73 - $ 8.97 B australiaAustralia
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
 		58.1 $ 333.39 - $ 43.7 B usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		28.1 $ 3.17 - $ 5.22 M israelIsrael
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
Aptinyx Aptinyx
APTX
 		46.9 - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
 		16.8 - -13.39 % $ 1.45 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		70.9 $ 21.68 - $ 1.01 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		182 - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
 		88.1 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		216 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
 		62.9 $ 1.55 - $ 399 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		0.114 - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		103 $ 4.24 - $ 453 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		106 $ 24.58 - $ 3.13 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		115 - -4.8 % $ 255 M usaUSA
Genmab A/S Genmab A/S
GMAB
 		97.9 $ 29.3 - $ 18.8 B danmarkDanmark
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		58.2 $ 1.49 - $ 397 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		6.83 - - $ 169 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
 		164 - -16.75 % $ 25.8 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		321 $ 33.87 - $ 2.25 B usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
 		61.7 - - $ 25.3 M usaUSA